Please assess the completion status of the following clinical trial:

Trial Title: The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* o Age: 7 - 21 years old~  * Currently has a tracheostomy tube~ * One of previous 3 tracheostomy tube aspirate cultures positive for Pseudomonas aeruginosa~ * Non-smoker~ * Ability of parent to provide informed consent, as evidenced by signing a copy of the consent form approved by the Institutional Review Board of the subject's respective study institution.~ * Written assent for children 7-17 years of age.~ * Informed consent for children ages 18-21, as evidence by signing a copy of the consent form approved by the Institutional Review Board of the subject's respective study institution.~Exclusion Criteria:~* o History of immunodeficiency~  * History of cystic fibrosis. Primary ciliary dyskinesia, or bronchiectasis~ * History of tuberculosis~ * History of positive culture for Burkholderia cepacia~ * Use of inhaled antibiotics in the last 6 months

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): All participants will be receiving the study drug

Based on this trial design, predict the completion outcome and termination type (if applicable).